Gene: PAQR7
Official Full Name: progestin and adipoQ receptor family member 7provided by HGNC
Gene Summary: Predicted to enable nuclear steroid receptor activity and steroid binding activity. Predicted to be involved in response to steroid hormone. Predicted to be located in membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03058 | PAQR7 Knockout cell line (HeLa) | Human | PAQR7 | 1:3~1:6 | Negative | Online Inquiry |
KO03059 | PAQR7 Knockout cell line (HCT 116) | Human | PAQR7 | 1:2~1:4 | Negative | Online Inquiry |
KO03060 | PAQR7 Knockout cell line (HEK293) | Human | PAQR7 | 1:3~1:6 | Negative | Online Inquiry |
KO03061 | PAQR7 Knockout cell line (A549) | Human | PAQR7 | 1:3~1:4 | Negative | Online Inquiry |
PAQR7 Gene Knockout Cell Lines represent a revolutionary tool for researchers investigating the biological roles of the PAQR7 gene, a key modulator in a variety of cellular processes, including lipid metabolism and cell signaling. These cell lines are engineered using CRISPR-Cas9 technology to create specific knockouts of the PAQR7 gene, enabling precise studies of gene function and its impact on cellular behavior.
The primary function of PAQR7 Gene Knockout Cell Lines revolves around their ability to facilitate the examination of the consequences of PAQR7 depletion on cellular pathways. By removing this gene, researchers can uncover its role in processes such as adipogenesis, hormone signaling, and metabolic regulation. The knockout model provides an ideal platform for functional studies, drug screening, and the elucidation of disease mechanisms, particularly in metabolic disorders and cancers where PAQR7 is implicated.
Scientifically, these cell lines hold significant importance in both basic and applied research contexts. They can be utilized to explore the interaction of PAQR7 with other signaling pathways and its effects on cell proliferation and differentiation. Furthermore, in a clinical setting, understanding PAQR7’s function could aid in the development of targeted therapies, making these cell lines essential for translational research.
What sets PAQR7 Gene Knockout Cell Lines apart from alternative models is their specificity and versatility. While traditional knockouts may rely on incomplete silencing techniques or less precise methods, these lines utilize a high-fidelity gene editing approach ensuring complete ablation of PAQR7 with minimal off-target effects. Additionally, our PAQR7 cell lines come with rigorous quality controls and are validated for reproducibility, making them a reliable choice for researchers.
For researchers and clinicians dedicated to advancing knowledge and therapeutic strategies related to metabolic diseases and oncology, PAQR7 Gene Knockout Cell Lines offer a unique opportunity to delve deeper into the complexities of gene function. Our company's expertise in genomic solutions and commitment to quality ensures that our products support cutting-edge research, paving the way for future breakthroughs in biological science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.